Meta-analysis of the interaction between HLA-DRB1 and smoking with Parkinson’s disease
Objective: To investigate interactions between HLA-DRB1 rs660895 polymorphisms and smoking in PD using meta-analysis to pool data from three large population-based studies. Background: Inflammatory response…Motor and Nonmotor clinical phenotype in LRRK2 Parkinson’s disease patients: a Case-control study
Objective: Our study aimed to characterize and compare the clinical phenotype of LRRK2-PD patients with PD patients with no identified mutations. Background: The clinical phenotype…Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality
Objective: Our goal was to examine the relationship between suicidality and motor fluctuations in Parkinson’s disease (PD) patients. Background: On/off motor fluctuations in PD are…Changes in motor subtype designation of early Parkinson’s disease patients
Objective: To examine changes in the designation of motor subtypes in Parkinson's disease (PD) patients within five years of diagnosis. Background: Distinct motor subtypes of…Medication optimization in Parkinson’s disease patients with ON-state freezing using objective gait assessments
Objective: To determine whether objective gait assessments could guide therapeutic decision making in Parkinson’s disease (PD) patients reporting freezing of gait (FOG) in the levodopa-ON…Diplopia: An Interesting Complication of Dropped Head Syndrome
Objective: To describe an interesting case of new-onset diplopia due to loss of compensation for trochlear nerve palsy as a result of dropped head in…Efficacy of IncobotulinumtoxinA in Treatment of Lower Limb Spasticity in Adults
Objective: To evaluate the effectiveness of incobotulinumtoxinA for treating key clinical patterns of lower limb (LL) spasticity (eg, pes equinovarus) using a post-hoc analysis. Background:…Long-term effect of botulinum toxin injection in the external oblique muscle to treat camptocormia in three patients with Parkinson’s disease.
Objective: To examine long-term effect of botulinum toxin injection (BTX) in the external oblique muscle (EO) for camptocormia associated with Parkinson’s disease (PD). Background: Camptocormia…WTX101 – A Novel Copper Modulating Agent for Wilson Disease Demonstrates Efficacy and Safety in a Phase 2, Multi-Center, Open Label Study
Objective: The objective of this study was to evaluate the efficacy and safety of 24 week WTX101 treatment in newly diagnosed Wilson Disease (WD) patients. Background:…Which factors predict patient satisfaction with botulinum toxin treatment for cervical dystonia?
Objective: Investigate which factors influence patient satisfaction with botulinum neurotoxin type A (BoNT-A) treatment for cervical dystonia (CD) in routine practice. Background: We have previously…
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 155
- Next Page »